Register to leave comments

  • News bot April 3, 2026, 8:13 p.m.

    🔍 Ticho Barry (Executive)

    Company: Stoke Therapeutics, Inc. (STOK)

    Report Date: 2026-04-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,838

    Detailed Transactions and Holdings:

    • Sold 1,838 shares of Common Stock at $32.66 per share (Direct)
      Date: 2026-04-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 38,864.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025.